Skip to main content
Erschienen in: Journal of Radiation Oncology 4/2016

07.11.2016 | Original Research

Nonoperative management of acoustic neuroma in geriatric patients: a National Cancer Database analysis

verfasst von: Shearwood McClelland III, Ellen Kim, James D. Murphy, Jerry J. Jaboin

Erschienen in: Journal of Radiation Oncology | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Background and purpose

The in-hospital mortality rate of surgery for acoustic neuroma (AN) is 0.5% and increases exponentially with age. There have been no studies examining the nationwide distribution of nonoperative management (radiation or observation) in the geriatric (≥ age 65) AN population.

Material and methods

The National Cancer Database (NCDB) from 2004 to 2013 identified geriatric AN patients. Multivariable logistic regression adjusted for patient age, race, sex, income, geographic region, primary payer for care, tumor size, and comorbidities.

Results

Of the 11,614 AN patients, 1725 (14.9%) were geriatric; median tumor size was 2.1 cm. Solitary treatment was administered as radiation (13%), observation (8.5%), and surgery (74.5%). Men (OR = 1.3, p = 0.03) and comprehensive cancer center (CCC) treatment (OR = 1.4, p = 0.02) were more likely to receive radiation. African-American race (OR = 1.5, p = 0.03) was associated with increased observation, while comorbidities (OR = 0.7, p = 0.03) were associated with decreased observation.

Conclusions

Fifteen percent of the AN population is ≥ age 65, with surgery the most commonly used treatment modality. Male gender and CCC treatment independently predict receipt of radiation, while African-American race independently predicts receipt of observation. Given the proven impact of radiation on local control in AN, there is fertile ground for dissemination of radiation treatment for geriatric AN patients.
Literatur
1.
Zurück zum Zitat DeLong M, Kirkpatrick J, Cummings T, Adamson DC (2011) Vestibular schwannomas: lessons for the neurosurgeon: part II: molecular biology and histology. Contemp Neurosurg 33(21):1–3CrossRef DeLong M, Kirkpatrick J, Cummings T, Adamson DC (2011) Vestibular schwannomas: lessons for the neurosurgeon: part II: molecular biology and histology. Contemp Neurosurg 33(21):1–3CrossRef
2.
Zurück zum Zitat (1991) Acoustic neuroma. NIH Consensus Statement, 9(4):1–24 (1991) Acoustic neuroma. NIH Consensus Statement, 9(4):1–24
3.
Zurück zum Zitat Babu R, Sharma R, Bagley JH et al (2013) Vestibular schwannomas in the modern era: epidemiology, treatment trends, and disparities in management. J Neurosurg 119(1):121–130CrossRefPubMed Babu R, Sharma R, Bagley JH et al (2013) Vestibular schwannomas in the modern era: epidemiology, treatment trends, and disparities in management. J Neurosurg 119(1):121–130CrossRefPubMed
4.
Zurück zum Zitat Bederson JB, Von Ammon K, Wichmann WW, Yasargil MG (1991) Conservative treatment of patients with acoustic tumors. Neurosurgery 28:646–651CrossRefPubMed Bederson JB, Von Ammon K, Wichmann WW, Yasargil MG (1991) Conservative treatment of patients with acoustic tumors. Neurosurgery 28:646–651CrossRefPubMed
5.
Zurück zum Zitat Laasonen EM, Troupp H (1986) Volume growth rate of acoustic neuromas. Neuroradiology 28:203–207CrossRefPubMed Laasonen EM, Troupp H (1986) Volume growth rate of acoustic neuromas. Neuroradiology 28:203–207CrossRefPubMed
6.
Zurück zum Zitat DeLong M, Kaylie D, Kranz PG, Adamson DC (2011) Vestibular schwannomas: lessons for the neurosurgeon: part I: diagnosis, neuroimaging, and audiology. Contemp Neurosurg 33(20):1–5CrossRef DeLong M, Kaylie D, Kranz PG, Adamson DC (2011) Vestibular schwannomas: lessons for the neurosurgeon: part I: diagnosis, neuroimaging, and audiology. Contemp Neurosurg 33(20):1–5CrossRef
7.
Zurück zum Zitat Haines SJ, Levine SC (1993) Intracanalicular acoustic neuroma: early surgery for preservation of hearing. J Neurosurg 79(4):515–520CrossRefPubMed Haines SJ, Levine SC (1993) Intracanalicular acoustic neuroma: early surgery for preservation of hearing. J Neurosurg 79(4):515–520CrossRefPubMed
8.
Zurück zum Zitat Sughrue ME, Yang I, Aranda D et al (2011) Beyond audiofacial morbidity after vestibular schwannoma surgery. J Neurosurg 114:367–374CrossRefPubMed Sughrue ME, Yang I, Aranda D et al (2011) Beyond audiofacial morbidity after vestibular schwannoma surgery. J Neurosurg 114:367–374CrossRefPubMed
9.
Zurück zum Zitat McClelland S 3rd, Guo H, Okuyemi KS (2011) Morbidity and mortality following acoustic neuroma excision in the United States: analysis of racial disparities during a decade in the radiosurgery era. Neuro-Oncology 13:1252–1259CrossRefPubMedPubMedCentral McClelland S 3rd, Guo H, Okuyemi KS (2011) Morbidity and mortality following acoustic neuroma excision in the United States: analysis of racial disparities during a decade in the radiosurgery era. Neuro-Oncology 13:1252–1259CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Lau T, Olivera R, Miller T Jr et al (2012) Paradoxical trends in the management of vestibular schwannoma in the United States. J Neurosurg 117(3):514–519CrossRefPubMed Lau T, Olivera R, Miller T Jr et al (2012) Paradoxical trends in the management of vestibular schwannoma in the United States. J Neurosurg 117(3):514–519CrossRefPubMed
11.
Zurück zum Zitat American College of Surgeons Commission on Cancer (2011) National Cancer Data Base, 2008 data submission. American College of Surgeons, Chicago American College of Surgeons Commission on Cancer (2011) National Cancer Data Base, 2008 data submission. American College of Surgeons, Chicago
12.
Zurück zum Zitat Park HS, Wang EH, Rutter CE, Corso CD, Chiang VL, Yu JB (2016) Changing practice patterns of gamma knife versus linear accelerator-based stereotactic radiosurgery for brain metastases in the US. J Neurosurg 124:1018–1024CrossRefPubMed Park HS, Wang EH, Rutter CE, Corso CD, Chiang VL, Yu JB (2016) Changing practice patterns of gamma knife versus linear accelerator-based stereotactic radiosurgery for brain metastases in the US. J Neurosurg 124:1018–1024CrossRefPubMed
13.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40:373–383CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40:373–383CrossRefPubMed
14.
Zurück zum Zitat Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613–619CrossRefPubMed Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613–619CrossRefPubMed
15.
Zurück zum Zitat Kondziolka D, Mousavi SH, Kano H, Flickinger JC, Lunsford LD (2012) The newly diagnosed vestibular schwannoma: radiosurgery, resection, or observation? Neurosurg Focus 33:E8CrossRefPubMed Kondziolka D, Mousavi SH, Kano H, Flickinger JC, Lunsford LD (2012) The newly diagnosed vestibular schwannoma: radiosurgery, resection, or observation? Neurosurg Focus 33:E8CrossRefPubMed
16.
Zurück zum Zitat Anderson BM, Khuntia D, Bentzen SM et al (2014) Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery. J Neuro-Oncol 116:187–193CrossRef Anderson BM, Khuntia D, Bentzen SM et al (2014) Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery. J Neuro-Oncol 116:187–193CrossRef
17.
Zurück zum Zitat Linskey ME, Lunsford LD, Flickinger JC, Kondziolka D (1992) Stereotactic radiosurgery for acoustic tumors. Neurosurg Clin N Am 3:191–205PubMed Linskey ME, Lunsford LD, Flickinger JC, Kondziolka D (1992) Stereotactic radiosurgery for acoustic tumors. Neurosurg Clin N Am 3:191–205PubMed
Metadaten
Titel
Nonoperative management of acoustic neuroma in geriatric patients: a National Cancer Database analysis
verfasst von
Shearwood McClelland III
Ellen Kim
James D. Murphy
Jerry J. Jaboin
Publikationsdatum
07.11.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Radiation Oncology / Ausgabe 4/2016
Print ISSN: 1948-7894
Elektronische ISSN: 1948-7908
DOI
https://doi.org/10.1007/s13566-016-0288-x

Weitere Artikel der Ausgabe 4/2016

Journal of Radiation Oncology 4/2016 Zur Ausgabe

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.